Market Value334,017,222
Total Holdings54
File Date2024-11-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
EWTX / Edgewise Therapeutics, Inc.
KROS / Keros Therapeutics, Inc.
DNLI / Denali Therapeutics Inc.
INSM / Insmed Incorporated
SRPT / Sarepta Therapeutics, Inc.
PRAX / Praxis Precision Medicines, Inc.
SLNO / Soleno Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
INCY / Incyte Corporation
MBX / MBX Biosciences, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
ROIV / Roivant Sciences Ltd.
CAPR / Capricor Therapeutics, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
DAWN / Day One Biopharmaceuticals, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
CLDX / Celldex Therapeutics, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
BDTX / Black Diamond Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc. Call
SRZN / Surrozen, Inc.
KALV / KalVista Pharmaceuticals, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
NGNE / Neurogene Inc.
NRIX / Nurix Therapeutics, Inc.
ATXS / Astria Therapeutics, Inc.
SLRN / Acelyrin, Inc.
VIGL / Vigil Neuroscience, Inc.
TCRX / TScan Therapeutics, Inc.
PYXS / Pyxis Oncology, Inc.
IMTX / Immatics N.V.
TRML / Tourmaline Bio, Inc.
PCSC / Perceptive Capital Solutions Corp
FOLD / Amicus Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
SYRE / Spyre Therapeutics, Inc.
BMY / Bristol-Myers Squibb Company
ZURA / Zura Bio Limited
ACLX / Arcellx, Inc.
BHVN / Biohaven Ltd.
IMVT / Immunovant, Inc. Call
IDYA / IDEAYA Biosciences, Inc.
MRUS / Merus N.V.
IMVT / Immunovant, Inc.
HLXB / Helix Acquisition Corp. II
VTGN / Vistagen Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
JSPR / Jasper Therapeutics, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
CABA / Cabaletta Bio, Inc.
BBIO / BridgeBio Pharma, Inc.
MRK / Merck & Co., Inc.
LRMR / Larimar Therapeutics, Inc.
ARQT / Arcutis Biotherapeutics, Inc. Call
ALKS / Alkermes plc
GSK / GSK plc - Depositary Receipt (Common Stock)
URGN / UroGen Pharma Ltd.
APLT / Applied Therapeutics, Inc. Call
APLT / Applied Therapeutics, Inc.
TARA / Protara Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
WVE / Wave Life Sciences Ltd.
CATX / Perspective Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.